Biotechnology
Compare Stocks
2 / 10Stock Comparison
MLEC vs SMPL
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
MLEC vs SMPL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Packaged Foods |
| Market Cap | $7M | $1.24B |
| Revenue (TTM) | $8M | $1.45B |
| Net Income (TTM) | $-8M | $91M |
| Gross Margin | -8.2% | 34.0% |
| Operating Margin | -116.7% | 14.4% |
| Forward P/E | — | 7.5x |
| Total Debt | $247M | $304M |
| Cash & Equiv. | $768K | $98M |
MLEC vs SMPL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Moolec Science S.A. (MLEC) | 100 | 92.6 | -7.4% |
| The Simply Good Foo… (SMPL) | 100 | 40.9 | -59.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MLEC vs SMPL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MLEC is the clearest fit if your priority is growth exposure.
- Rev growth 58.3%, EPS growth -89.8%
- 58.3% revenue growth vs SMPL's 9.0%
- -2.0% vs SMPL's -64.8%
SMPL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.38
- 3.7% 10Y total return vs MLEC's -8.5%
- Lower volatility, beta 0.38, Low D/E 16.8%, current ratio 3.64x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 58.3% revenue growth vs SMPL's 9.0% | |
| Quality / Margins | 6.3% margin vs MLEC's -105.7% | |
| Stability / Safety | Beta 0.38 vs MLEC's 0.89 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -2.0% vs SMPL's -64.8% | |
| Efficiency (ROA) | 3.7% ROA vs MLEC's -26.6%, ROIC 8.1% vs -8.8% |
MLEC vs SMPL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MLEC vs SMPL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SMPL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SMPL is the larger business by revenue, generating $1.4B annually — 185.1x MLEC's $8M. SMPL is the more profitable business, keeping 6.3% of every revenue dollar as net income compared to MLEC's -105.7%. On growth, MLEC holds the edge at +9.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $8M | $1.4B |
| EBITDAEarnings before interest/tax | -$8M | $231M |
| Net IncomeAfter-tax profit | -$8M | $91M |
| Free Cash FlowCash after capex | -$6M | $174M |
| Gross MarginGross profit ÷ Revenue | -8.2% | +34.0% |
| Operating MarginEBIT ÷ Revenue | -116.7% | +14.4% |
| Net MarginNet income ÷ Revenue | -105.7% | +6.3% |
| FCF MarginFCF ÷ Revenue | -78.1% | +12.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.5% | -0.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.0% | -31.6% |
Valuation Metrics
MLEC leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
On an enterprise value basis, SMPL's 6.0x EV/EBITDA is more attractive than MLEC's 21.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $7M | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $253M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -0.03x | 12.20x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.51x |
| EV / EBITDAEnterprise value multiple | 21.45x | 5.97x |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 0.86x |
| Price / BookPrice ÷ Book value/share | — | 0.70x |
| Price / FCFMarket cap ÷ FCF | — | 7.86x |
Profitability & Efficiency
SMPL leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
SMPL delivers a 5.2% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-151 for MLEC. On the Piotroski fundamental quality scale (0–9), SMPL scores 5/9 vs MLEC's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -150.9% | +5.2% |
| ROA (TTM)Return on assets | -26.6% | +3.7% |
| ROICReturn on invested capital | -8.8% | +8.1% |
| ROCEReturn on capital employed | — | +9.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | — | 0.17x |
| Net DebtTotal debt minus cash | $246M | $206M |
| Cash & Equiv.Liquid assets | $767,919 | $98M |
| Total DebtShort + long-term debt | $247M | $304M |
| Interest CoverageEBIT ÷ Interest expense | -2.94x | 6.77x |
Total Returns (Dividends Reinvested)
Evenly matched — MLEC and SMPL each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MLEC five years ago would be worth $9,201 today (with dividends reinvested), compared to $3,565 for SMPL. Over the past 12 months, MLEC leads with a -2.0% total return vs SMPL's -64.8%. The 3-year compound annual growth rate (CAGR) favors SMPL at -31.5% vs MLEC's -33.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +3153.6% | -36.4% |
| 1-Year ReturnPast 12 months | -2.0% | -64.8% |
| 3-Year ReturnCumulative with dividends | -70.1% | -67.8% |
| 5-Year ReturnCumulative with dividends | -8.0% | -64.3% |
| 10-Year ReturnCumulative with dividends | -8.5% | +3.7% |
| CAGR (3Y)Annualised 3-year return | -33.1% | -31.5% |
Risk & Volatility
Evenly matched — MLEC and SMPL each lead in 1 of 2 comparable metrics.
Risk & Volatility
SMPL is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than MLEC's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MLEC currently trades 38.7% from its 52-week high vs SMPL's 33.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.38x |
| 52-Week HighHighest price in past year | $23.22 | $36.92 |
| 52-Week LowLowest price in past year | $0.20 | $10.21 |
| % of 52W HighCurrent price vs 52-week peak | +38.7% | +33.7% |
| RSI (14)Momentum oscillator 0–100 | 51.3 | 42.9 |
| Avg Volume (50D)Average daily shares traded | 319K | 2.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $20.17 |
| # AnalystsCovering analysts | — | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +14.2% | +4.1% |
SMPL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MLEC leads in 1 (Valuation Metrics). 2 tied.
MLEC vs SMPL: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MLEC or SMPL a better buy right now?
For growth investors, Moolec Science S.
A. (MLEC) is the stronger pick with 58. 3% revenue growth year-over-year, versus 9. 0% for The Simply Good Foods Company (SMPL). The Simply Good Foods Company (SMPL) offers the better valuation at 12. 2x trailing P/E (7. 5x forward), making it the more compelling value choice. Analysts rate The Simply Good Foods Company (SMPL) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MLEC or SMPL?
Over the past 5 years, Moolec Science S.
A. (MLEC) delivered a total return of -8. 0%, compared to -64. 3% for The Simply Good Foods Company (SMPL). Over 10 years, the gap is even starker: SMPL returned +3. 7% versus MLEC's -8. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MLEC or SMPL?
By beta (market sensitivity over 5 years), The Simply Good Foods Company (SMPL) is the lower-risk stock at 0.
38β versus Moolec Science S. A. 's 0. 89β — meaning MLEC is approximately 135% more volatile than SMPL relative to the S&P 500.
04Which is growing faster — MLEC or SMPL?
By revenue growth (latest reported year), Moolec Science S.
A. (MLEC) is pulling ahead at 58. 3% versus 9. 0% for The Simply Good Foods Company (SMPL). On earnings-per-share growth, the picture is similar: The Simply Good Foods Company grew EPS -26. 1% year-over-year, compared to -89. 8% for Moolec Science S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MLEC or SMPL?
The Simply Good Foods Company (SMPL) is the more profitable company, earning 7.
1% net margin versus -33. 4% for Moolec Science S. A. — meaning it keeps 7. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMPL leads at 15. 1% versus -3. 1% for MLEC. At the gross margin level — before operating expenses — SMPL leads at 35. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MLEC or SMPL?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MLEC or SMPL better for a retirement portfolio?
For long-horizon retirement investors, The Simply Good Foods Company (SMPL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
38)). Both have compounded well over 10 years (SMPL: +3. 7%, MLEC: -8. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MLEC and SMPL?
These companies operate in different sectors (MLEC (Healthcare) and SMPL (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MLEC is a small-cap high-growth stock; SMPL is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.